Publications by authors named "M Haluzik"
Article Synopsis
- * The condition significantly impacts life expectancy and healthcare costs, as it has a high 5-year mortality rate of 60-70%.
- * Advances in treatment options have emerged, including new medications and surgical solutions like heart transplantation and left ventricular assist devices, while further research is needed on diagnostics and therapies for heart failure.
Obesity is a complex health issue with growing prevalence worldwide. It is also becoming more prevalent in the population of older adults (i.e.
View Article and Find Full Text PDFArticle Synopsis
- Metabolic-dysfunction-associated steatotic liver disease (MASLD) is a significant issue tied to obesity, prompting a study on the impact of semaglutide, a medication for weight loss.
- The study involved 16 obese, non-diabetic men over 32 weeks, revealing that semaglutide reduced body weight and liver fat significantly, while dietary changes did not influence these outcomes.
- Notably, changes in liver fat were not linked to weight loss or improved insulin sensitivity, but the treatment did lower certain fatty acids in VLDL-triglycerides, indicating it might reduce liver fat by decreasing new fat production in the liver.